(Q39998127)

English

Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

M Guan

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

V Tripathi

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

X Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

N C Popescu

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

28 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

371-381

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Trends and patterns of prostate cancer: what do they suggest?

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Cytogenetics and molecular genetics of cancer of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

DLC-1: a Rho GTPase-activating protein and tumour suppressor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Gene therapy for prostate cancer: current strategies and new cell-based approaches

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Adenoviral strategies for the gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

A multigenic program mediating breast cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Antisense Bcl-2 sensitizes prostate cancer cells to radiation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor suppressor gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo models of prostate cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2008.13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39998127&oldid=2203307827"